1. Academic Validation
  2. The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER

The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER

  • J Cell Biol. 2009 Sep 7;186(5):685-92. doi: 10.1083/jcb.200906110.
Helen R Stagg 1 Mair Thomas Dick van den Boomen Emmanuel J H J Wiertz Harry A Drabkin Robert M Gemmill Paul J Lehner
Affiliations

Affiliation

  • 1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB20XY, England, UK.
Abstract

The US2 and US11 gene products of human cytomegalovirus promote viral evasion by hijacking the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. US2 and US11 initiate dislocation of newly translocated major histocompatibility complex class I (MHC I) from the ER to the cytosol for proteasome-mediated degradation, thereby decreasing cell surface MHC I. Despite being instrumental in elucidating the mammalian ERAD pathway, the responsible E3 ligase or ligases remain unknown. Using a functional small interfering RNA library screen, we now identify TRC8 (translocation in renal carcinoma, chromosome 8 gene), an ER-resident E3 ligase previously implicated as a hereditary kidney Cancer gene, as required for US2-mediated MHC I ubiquitination. Depletion of TRC8 prevents MHC I ubiquitination and dislocation by US2 and restores cell surface MHC I. TRC8 forms an integral part of a novel multiprotein ER complex that contains MHC I, US2, and signal peptide peptidase. Our data show that the TRC8 E3 ligase is required for MHC I dislocation from the ER and identify a new complex associated with mammalian ERAD.

Figures